Outcomes of COVID-19 restrictions on patients with type 2 diabetes in Turkiye

Authors : Mustafa Aydemir, Hasan Sözel

Pages : 162-166

Doi:10.32322/jhsm.1601560

View : 33 | Download : 34

Publication Date : 2025-03-21

Article Type : Research Paper

Abstract :Aims: This study aimed to assess the impact of the national COVID-19 lockdown in Turkiye, initiated in March 2020, on glycemic and lipid parameters in patients with type 2 diabetes mellitus (T2DM). Methods: We included T2DM patients who visited Akdeniz University Hospital between 11.03.2019 and 10.03.2021. Clinical and laboratory data (age, gender, blood glucose, serum creatinine, LDL, triglyceride, HDL, hemoglobin, HbA1c) were retrieved from the hospital database for analysis. Results: A total of 1,715 T2DM patients were included, with 828 males (48.2%) and 887 females (51.8%). The number of patients seen before and during the pandemic was 930 and 785, respectively. The mean glucose levels before and during the pandemic were 153 mg/dl (149.25-157.47) and 165 mg/dl (160.14-170.62), respectively (p<0.001). HbA1c levels increased from 8.11% (7.99-8.23) to 8.30% (8.16-8.43) (p=0.046). Triglyceride levels rose from 189.17 mg/dl (181.13-197.21) to 215.12 mg/dl (202.80-227.45) (p=0.001). Significant deterioration in glucose (p<0.000), triglycerides (p<0.001), and HbA1c (p=0.046) levels was observed during the pandemic. Conclusion: The COVID-19 lockdown negatively impacted the glycemic control and lipid profiles of patients with type 2 diabetes, indicating a potential worsening of metabolic parameters during this period.
Keywords : Diyabet mellitus, COVID-19, diyabet komplikasyonları